Acute kidney injury (AKI) signifies a sudden and prolonged decline in kidney function characterized by tubular cell death and interstitial i...
T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% of pediatric and 25% of adult cases of acute lymphoblastic leukemia (ALL). Even...
Some gut bacteria can collaborate to promote T-cell action against tumours in mice, raising hopes for treatments.A new study led by Zhejiang...
Early-stage oral tongue squamous cell carcinoma (OTSCC) comprises 25‒40% of oral cancer, and has relatively poorer survival outcomes compare...
Bone is one of the most common sites of early metastasis of cancer and is also a hotbed for tumor cells. Why do tumor cells go after hard bo...
Bipolar disorder is a severe and disabling psychiatric disorderwith the potentialfor adverse outcomes, such as suicide, if patient...
On March 5, the research team led by Professors YU Yanqin, DUAN Shumin and YANG Hongbin from the Zhejiang Universit...
A team of researchers from the Bird 10,000 Genomes (B10K) consortium, initiated by Professor ZHANG Guojie of Centre for Evolutionary & O...
Myocardial hypertrophy, characterized by an increase in cardiac muscle mass, is an adaptive response to pathological stimuli such as hyperte...
Excessive or repetitive fear play a significant role in the development of anxiety disorders, with the amygdala serving as the central locus...
The breakthrough achieved by chimeric antigen receptor (CAR) T cells in the treatment of hematologic malignancies undoubtedly represents the...
Bipolar disorder is a recurrent debilitating mental illness with a complex aetiology. According to the Global Burden of Disease (GBD) Study ...
Addressing the long-standing Cannabis problem, an oddity that has vexed scientists for decades, joint research by Professor L...
The heterogeneity of cancer cells and the underlying drivers play a crucial role in understanding tumorigenesis, malignant progression, and ...
Her2-Positive Gastric Cancer accounts for approximately 20% of all gastric cancers, and trastuzumab in combination with chemotherapy remains...